IRCT20140804018677N24Not yet recruitingPhase 3
The effect of high-dose of vitamin B1 supplementation on serum CGRP neuropeptide levels and features of episodic migraine in women
Shahid Beheshti University of Medical Sciences, Nutrition and Food Industries Research Institute0 sites40 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 40
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 45 years (—)
- Sex
- Female
Inclusion Criteria
- •Willingness to participate in the study
- •18 to 45 years old
- •BMI between 18.5-30
- •Diagnosis of episodic migraine headache based on the criteria of the Classification Committee of the International Headache Society (IHS) 3rd edition (beta version)
- •Suffering from headache for more than three months
- •Not taking a new medication to prevent migraine headache or changing its dose in the last 2 months
Exclusion Criteria
- •Vitamin B1 supplement consumption with any dose and consumption of any type of multivitamin containing vitamin B1 during the last three months
- •Pregnancy and lactation
- •Use of antipsychotic drugs
- •Having known gastrointestinal diseases (malabsorption, IBD, etc.), diabetes, liver disorders (cirrhosis and types of hepatitis), kidney disorders (renal failure), congestive heart failure, high blood pressure, cancer
Investigators
Similar Trials
Recruiting
Not Applicable
Vitamin B Multivitamin Supplement on Neural Connectivity and Oxidative MetabolismCognitive declineOxidative StressAlternative and Complementary Medicine - Other alternative and complementary medicineNeurological - Other neurological disordersInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12622001150730Taylor's University90
Recruiting
Phase 3
Assessment of the vitamin B1 effect on the outcomes of patients with sepsisOther sepsisSepsis.IRCT20220711055432N1Oroumia University of Medical Sciences56
Completed
Phase 2
Vitamin B1 (thiamine) administration in enterally-fed critically ill patients with hypophosphatemia: A prospective, randomised clinical trialHypophosphatemiaCritical illnessenteral nutritionMetabolic and Endocrine - Other metabolic disordersDiet and Nutrition - Other diet and nutrition disordersThiamine deficiencyACTRN12619000121167Royal Melbourne Hospital90
Completed
Unknown
Investigating the effect of vitamin B1 oral tablets on the post covid-19 syndromePost covid-19 syndrome.COVID-19, virus identifiedU07.1IRCT20221229056979N1Shahid Beheshti University of Medical Sciences60
Not yet recruiting
Phase 2
Evaluating the effect of thiamine on deliriumIRCT20190224042815N1Tehran University of Medical Sciences90